Literature DB >> 10342317

Transfer of porcine endogenous retrovirus across hollow fiber membranes: significance to a bioartificial liver.

S L Nyberg1, J R Hibbs, J A Hardin, J J Germer, D H Persing.   

Abstract

BACKGROUND: A porcine endogenous retrovirus (PERV) capable of infecting human cells has been identified. This study was designed to determine whether hollow fiber membranes, such as those used in a bioartificial liver, block the transfer of PERV.
METHODS: Three hollow fiber cartridges (HFCs) were studied in duplicate: cellulose fibers with 70 kD nominal molecular weight cut-off (MWCO), polysulfone fibers with 400 kD MWCO, and mixed cellulose fibers with 200 nm porosity. PK15 cells (porcine kidney cell line), known to produce PERV, were grown in the intraluminal compartment of HFCs fiber cartridges. Samples of medium were collected from both intraluminal and extraluminal compartments of the HFCs fiber cartridge during 14 days of culture. Samples were screened for PERV using reverse transcription polymerase chain reaction. All positive samples were tested for PERV infectivity in human 293 cells.
RESULTS: PERV was detected in all samples from the intraluminal space and all intraluminal samples seemed to infect 293 cells. All extraluminal samples from the fibers of 200 nm porosity tested positive for PERV. Detection of PERV in the extraluminal space was delayed by fibers of 400 kD MWCO and 70 kD MWCO until at least day 3 and day 7, respectively, after inoculation of PK15 cells. Positive extraluminal samples from fibers of 400 kD MWCO and 70 kD MWCO did not infect 293 cells.
CONCLUSION: Pore size, membrane composition, and duration of exposure influenced the transfer of PERV across HFCs. Some HFCs decrease the risk of viral exposure to patients during bioartificial liver therapy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10342317     DOI: 10.1097/00007890-199905150-00009

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  10 in total

Review 1.  Cell therapies for liver diseases.

Authors:  Yue Yu; James E Fisher; Joseph B Lillegard; Brian Rodysill; Bruce Amiot; Scott L Nyberg
Journal:  Liver Transpl       Date:  2012-01       Impact factor: 5.799

Review 2.  Prospects for extracorporeal liver support.

Authors:  R Jalan; S Sen; R Williams
Journal:  Gut       Date:  2004-06       Impact factor: 23.059

3.  Pivotal preclinical trial of the spheroid reservoir bioartificial liver.

Authors:  Jaime M Glorioso; Shennen A Mao; Brian Rodysill; Taufic Mounajjed; Walter K Kremers; Faysal Elgilani; Raymond D Hickey; Hakon Haugaa; Christopher F Rose; Bruce Amiot; Scott L Nyberg
Journal:  J Hepatol       Date:  2015-03-25       Impact factor: 25.083

Review 4.  Infectious disease issues in xenotransplantation.

Authors:  R S Boneva; T M Folks; L E Chapman
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

Review 5.  Bioartificial liver support anno 2001.

Authors:  Robert A F M Chamuleau
Journal:  Metab Brain Dis       Date:  2002-12       Impact factor: 3.584

6.  Detection of PERV by polymerase chain reaction and its safety in bioartificial liver support system.

Authors:  Hai-Hui Wang; Ying-Jie Wang; Hong-Ling Liu; Jun Liu; Yan-Ping Huang; Hai-Tao Guo; Yu-Ming Wang
Journal:  World J Gastroenterol       Date:  2006-02-28       Impact factor: 5.742

7.  Present and Future Developments in Hepatic Tissue Engineering for Liver Support Systems : State of the art and future developments of hepatic cell culture techniques for the use in liver support systems.

Authors:  Sonja Diekmann; Augustinus Bader; Stephanie Schmitmeier
Journal:  Cytotechnology       Date:  2006-06-23       Impact factor: 2.058

8.  Microbiological safety of a novel bio-artificial liver support system based on porcine hepatocytes: a experimental study.

Authors:  Bing Han; Xiao-Lei Shi; Yue Zhang; Xue-Hui Chu; Jin-Yang Gu; Jiang-Qiang Xiao; Hao-Zhen Ren; Jia-Jun Tan; Zhong-Ze Gu; Yi-Tao Ding
Journal:  Eur J Med Res       Date:  2012-05-25       Impact factor: 2.175

9.  Novel spheroid reservoir bioartificial liver improves survival of nonhuman primates in a toxin-induced model of acute liver failure.

Authors:  Yi Li; Qiong Wu; Yujia Wang; Chengxin Weng; Yuting He; Mengyu Gao; Guang Yang; Li Li; Fei Chen; Yujun Shi; Bruce P Amiot; Scott L Nyberg; Ji Bao; Hong Bu
Journal:  Theranostics       Date:  2018-11-09       Impact factor: 11.556

Review 10.  Xenotransplantation, xenogeneic infections, biotechnology, and public health.

Authors:  Louisa E Chapman
Journal:  Mt Sinai J Med       Date:  2009-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.